Courses List

0
No products in the cart.
← Literature Database

Risk factors survey for extracorporeal shockwave lithotripsy-induced renal hematoma.

Practice Point

Hsiang-ying Lee, Yi-Hsin Yang, Jung-Tsung Shen, Mei-Yu Jang, Paul Ming-Chen Shih, Wen-Jeng Wu, Chun-Hsiung Huang, Yii-her Chou, Yung-Shun Juan

Journal of endourology · 2013 · Vol. 27 · Issue 6 · 763-7

PMID: 23272952 DOI: 10.1089/end.2012.0619

Academy Summary

Lee and colleagues evaluated risk factors associated with subcapsular or perirenal haematoma following shock wave lithotripsy (SWL) in a large clinical series.

Between 2001 and 2011, 6,177 patients underwent 10,887 SWL treatment sessions for urinary stones. All procedures were performed using a Siemens Lithostar Multiline lithotripter at approximately 2 shocks/second (120 shocks/min) with intermittent fluoroscopic targeting.

Twenty patients developed a diagnosed subcapsular or perirenal haematoma. The authors reported an incidence of 0.32%, which corresponds to 20 events among 6,177 patients. When calculated per treatment session, the incidence was approximately 0.18% (20/10,887).

Eighteen of the 20 affected patients developed flank pain, while two haematomas were discovered incidentally. Four patients required blood transfusion because of significant haemoglobin reduction, but all patients were successfully managed conservatively without surgical exploration.

Hypertension was present in 50% of patients who developed haematoma. More than half of the cases, 11 of 20, occurred after a second or third SWL treatment.

In the comparative risk-factor analysis, hypertension, higher BMI, and larger stone size were significantly associated with renal haematoma formation.

The study therefore reinforces the importance of identifying patient and stone characteristics that may increase susceptibility to bleeding before SWL and recognising severe or persistent flank pain after treatment as a potential warning sign.

Unlock the Academy Interpretation for Free

Create a free Lithotripsy Academy account or log in to access the complete Academy interpretation, including Key Findings, Clinical Takeaway, Limitations, and Expert Commentary

Subscribe to View Details Already a member? Log in
Comments & Discussion0 comments

Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.

No comments yet. Start the discussion.